Loading
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Previous close
$6.60
+$0.08 · +1.23%
Regular session · ET · Market data may be delayed.
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Day range
Current $6.60
52-week range
Current $6.60
Regular session · ET · Market data may be delayed.
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Day range
Current $6.60
52-week range
Current $6.60
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 13.55M USD | 11.76M USD | 9.75M USD |
| Cost of goods sold | 6.38M USD | 5.38M USD | 4.26M USD |
| Gross profit | 7.17M USD | 6.38M USD | 5.49M USD |
| Research and development | 18.31M USD | 15.12M USD | 9.33M USD |
| Selling, general, and administrative | 14.38M USD | 11.17M USD | 7.51M USD |
| Operating expenses | 32.69M USD | 26.29M USD | 16.84M USD |
| Interest income | 269K USD | 26K USD | 49K USD |
| Depreciation and amortization | 567K USD | 521K USD | 388K USD |
| Operating income | −25.52M USD | −19.92M USD | −11.35M USD |
| Net income | −25.32M USD | −19.9M USD | −11.31M USD |
Company facts updated Sep 12, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$9.00
36.36% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI6.09M0.00%2.3T USD0.03%$376.31+0.82%
iShares Russell 2000 ETFIWM5.25M0.01%77.55B USD0.19%$288.89+0.41%
iShares Russell 2000 Growth ETFIWO2.09M0.01%14.32B USD0.24%$367.63+0.54%
Vanguard Russell 2000 ETFVTWO1.29M0.01%17.4B USD0.06%$116.76+0.36%
iShares Micro-Cap ETFIWC754.71K0.05%1.44B USD0.60%$190.84+0.39%
Vanguard Extended Market ETFVXF664.47K0.00%93.7B USD0.05%$237.76+0.68%
Vanguard Russell 2000 Growth ETFVTWG244.9K0.01%1.7B USD0.06%$268.4+0.57%
Global X - Russell 2000 ETFRSSL109.37K0.01%1.47B USD0.08%$113.11+0.42%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCVanguard Extended Market ETFVXFVanguard Russell 2000 Growth ETFVTWGGlobal X - Russell 2000 ETFRSSLAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
